Furthermore, in vivo study showed that liver-specific overexpression of LPL increased levels of TG and cholesterol in the mice livers and promoted NAFLD progression (Fig. S3A). This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.